Faizan Farooque

Faizan Farooque

InvestorPlace Contributor

Expertise: Real estate investment trusts (REITs), SPACs, Cryptocurrencies

Education: BSc (Hons) Degree in Applied Accounting, Oxford Brookes University; Introduction to Data Analysis Using Excel, Rice University; Excel Skills for Business: Intermediate, Macquarie University

About Faizan
Faizan Farooque is a finance journalist who has reported on the latest trends in the stock market for many years. He helps people by providing advice about saving and investing and keeping up with what’s happening in the financial world.

Faizan is writing for InvestorPlace.com, GuruFocus, and TipRanks and has previously worked as a financial journalist and data analyst for S&P Global. He can analyze company filings from sources like SEC, FINRA, and others to help identify potential investment opportunities. Researching specific industries is also something he does to provide industry insight for clients.

Faizan deeply understands the market and how to read the financial tea leaves to anticipate where things are headed. His expertise gives readers an insider’s perspective on what’s happening in the finance world so they can make smart decisions.

Recent Articles

Don’t Get Caught up in the Enthusiasm Over Plug Power Stock at These Levels

By Faizan Farooque, InvestorPlace Contributor

PLUG stock is surging, but not due to fundamental strength. Instead, the enthusiasm surrounding alternate energy is boosting the stock to unrealistic levels.

GE Stock Will Continue to Suffer, and Here Are 3 Reasons Why

By Faizan Farooque, InvestorPlace Contributor

GE stock will continue to limp because Covid-19 is battering a company that is already struggling due to high debt and unprofitable segments.

3 Reasons Why Cisco Stock Is a Great Investment

By Faizan Farooque, InvestorPlace Contributor

Cisco stock is trading at a steep discount to historic highs and the sector, despite having excellent prospects and a wide moat. That makes it a steal at current rates.

Time Is Running Out on Inovio as Other Vaccine Candidates Advance

By Faizan Farooque, InvestorPlace Contributor

The FDA's latest decision has dealt a killer blow to INO stock, which was already struggling to keep up with Big Pharma in the vaccine race.

Coronavirus Hype Is Pushing Novavax to Unrealistic Highs

By Faizan Farooque, InvestorPlace Contributor

NVAX stock has to produce the goods before the markets reward it again, as brownie points for gathering funds will only take them so far.

Load More